News

The company will also make the UK the global centre of a major new clinical trial to investigate the use of inclisiran in improving cardiovascular outcomes.

Despite the recent approval of some high-profile nucleic acid therapy drugs, success has been modest, and there is still a “huge burden” of unmet medical need due to the vast number of diseases that are untreatable with traditional therapies.

The EMA also recently validated a Marketing Authorisation Application for the drug.

The number of patients with multiple long-term conditions is going up as the population ages, putting pressure on primary and secondary care.

Almost 1,800 new nursing apprentices have already started their training over the last couple of years.

The process is intended for for extremely rare conditions.

A research team forced cancer cells in the lab to evolve much more rapidly than usual using a molecule called APOBEC3B, which could then be used to create a vaccine for each individual cancer type.

China’s National Health Commission has confirmed a virus death toll rise to 908, surpassing the toll from the SARS epidemic of 2002-3, according to official data.

Alzheimer’s is a complex disease and one of the largest challenges facing healthcare today, with lots of failed treatments in past pipelines.

Experts are calling for the hormone to be offered as standard in the NHS for women with early pregnancy bleeding and a history of miscarriage.

The two separate ventures are part of a drive to expand the latest technological innovations and digital solutions in ophthalmology.

Risdiplam is the first potential treatment to have pivotal placebo-controlled data in a broad population of patients, including children, teenagers and adults.

Until now, previous studies just focused on the 1% of the genome that codes for proteins.

The Academy of Medical Royal Colleges and Faculties in Scotland’s plan responds to the fact that the landscape of healthcare is changing considerably.